Last Updated: November 10, 2026

CONDYLOX Drug Patent Profile

Name: CONDYLOX Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Condylox, and when can generic versions of Condylox launch?

Condylox is a drug marketed by Allergan and Teva Branded Pharm and is included in two NDAs.

The generic ingredient in CONDYLOX is podofilox. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the podofilox profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Condylox

A generic version of CONDYLOX was approved as podofilox by PADAGIS US on January 29^th, 2002.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for CONDYLOX?
What are the global sales for CONDYLOX?
What is Average Wholesale Price for CONDYLOX?

Summary for CONDYLOX

US Patents:	0
Applicants:	2
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	96
Clinical Trials:	1
Patent Applications:	4,833
Drug Prices:	Drug price information for CONDYLOX
What excipients (inactive ingredients) are in CONDYLOX?	CONDYLOX excipients list
DailyMed Link:	CONDYLOX at DailyMed

Drug patent expirations by year for CONDYLOX

Recent Clinical Trials for CONDYLOX

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Hyloris Developments SA	Phase 3
bioRASI, LLC	Phase 3
Dermax SA	Phase 3

See all CONDYLOX clinical trials

US Patents and Regulatory Information for CONDYLOX

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Allergan	CONDYLOX	podofilox	GEL;TOPICAL	020529-001	Mar 13, 1997		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Teva Branded Pharm	CONDYLOX	podofilox	SOLUTION;TOPICAL	019795-001	Dec 13, 1990		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for CONDYLOX

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	CONDYLOX	podofilox	GEL;TOPICAL	020529-001	Mar 13, 1997	⤷ Start Trial	⤷ Start Trial
Allergan	CONDYLOX	podofilox	GEL;TOPICAL	020529-001	Mar 13, 1997	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for CONDYLOX

See the table below for patents covering CONDYLOX around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Austria	48427		⤷ Start Trial
Austria	63916		⤷ Start Trial
Canada	1268709	PROCEDE D'ISOLEMENT ET DE PURIFICATION DE LA PODOPHYLLOTOXINE (PROCESS FOR THE ISOLATION AND PURIFICATION OF PODOPHYLLOTOXIN)	⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.